Ex Parte Roback et alDownload PDFPatent Trial and Appeal BoardJun 27, 201611679581 (P.T.A.B. Jun. 27, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 111679,581 02/27/2007 24504 7590 06/29/2016 THOMAS I HORSTEMEYER, LLP 400 INTERSTATE NORTH PARKWAY SE SUITE 1500 ATLANTA, GA 30339 FIRST NAMED INVENTOR John D. Roback UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 50508-1032 3785 EXAMINER HURST, JONATHAN M ART UNIT PAPER NUMBER 1799 NOTIFICATION DATE DELIVERY MODE 06/29/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): uspatents@tkhr.com kristen.layton@tkhr.com ozzie. liggins@tkhr.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte JOHN D. ROBACK, and CHRISTOPHER D. HILL YER Appeal2015-000424 Application 11/679,581 Technology Center 1700 Before ROMULO H. DELMENDO, MICHAEL P. COLAIANNI, and LILAN REN, Administrative Patent Judges. COLAIANNI, Administrative Patent Judge. DECISION ON APPEAL Appeal2015-000424 Application 11/679,581 Appellants appeal under 35 U.S.C. § 134 the final rejection of claims 1, 2, 4--9, 25, 27, 28, 30, and 31. We have jurisdiction over the appeal pursuant to 35 U.S.C. § 6(b). We AFFIRM. Appellants' invention is directed to immunologic assay systems and methods for separating components of immunological and immunohematological samples (Spec. i-f 1 ). Appellants' system uses a filter 150 comprising a mesh or a membrane of an inert material including a plurality of pores (claims 1, 25, 30, and 31; Fig. 2). Claim 1 is illustrative: 1. An immunological assay system, comprising: a filter vessel having a filter, wherein the filter vessel is capable of containing an assay sample comprising cellular components and wherein the filter comprises a mesh or a membrane of an inert material including a plurality of pores; an incubator configured to house the filter vessel while the assay sample and one or more antibody reagents react in an assay mixture; a sample separation system adjacent and within reaching distance of a robotic arm from the incubator, the sample separation system being configured to house the filter vessel and separate the cellular components of the assay sample and the antibody reagents into various reacted components above the filter; an image acquisition system adjacent and within reaching distance of a robotic arm from the sample separation system, the image acquisition system being configured to house the filter vessel and detect the presence of interactions between the cellular components and antibody reagents of the assay mixture above the filter in the filter vessel, the image acquisition system comprising a camera or a flow cytometer; and a robotic pipettor including a robotic arm within reaching distance of the filter vessel, the incubator, the sample separation system and the image acquisition system, the robotic pipettor being 2 Appeal2015-000424 Application 11/679,581 configured to transfer the sample or the reagents between the filter vessel, incubator, the sample separation system. Appellants appeal the following rejections: 1. Claims 1, 4---6, 8, and 30 are rejected under 35 U.S.C. § 103(a) as unpatentable over Longoria (US 4,948, 726, issued Aug. 14, 1990) in view ofYaremko et al., (hereinafter "Yaremko" US 5,620,898, issued Apr. 15, 1997). 2. Claim 2 is rejected under 35 U.S.C. § 103(a) as unpatentable over Longoria in view ofYaremko, and Imai et al., (US 5,543,292, issued Aug. 6, 1996). 3. Claim 7 is rejected under 35 U.S.C. § 103(a) as unpatentable over Longoria in view ofYaremko and Brown et al., (US 6,365,731 Bl, issued Apr. 2, 2002). 4. Claim 9 is rejected under 35 U.S.C. § 103(a) as unpatentable over Longoria in view ofYaremko, and Franciskovich (US 5,603,899, issued Feb. 18, 1997). 5. Claims 25 1, 27, and 31 are rejected under 35 U.S.C. § 103(a) as unpatentable over Longoria in view of Y aremko, and Waggoner (US 5,486,616, issued Jan. 23, 1996). 6. Claim 28 is rejected under 35 U.S.C. § 103(a) as unpatentable over Longoria in view of Y aremko, Waggoner and Franciskovich. Appellants do not appeal the Examiner's double patenting rejections listed on pages 15-21 of the Final Action. In an after-final response, 1 Claims 25 and 31 use means-plus-function language that invokes 35 U.S.C. § 112, i-f 6. Appellants do not dispute the Examiner's interpretation of the structure of the means-plus-function claim language and how the prior art reads on the construed claim language. 3 Appeal2015-000424 Application 11/679,581 Appellants indicated that terminal disclaimer would be filed upon indication of allowable subject matter (After-Final Amd't dated Dec. 17, 2013, 7-8). Accordingly, the still pending double patenting rejection are summarily affirmed. Regarding rejections (1) to (6), Appellants argue subject matter common to independent claims 1, 25, 30, and 31 (App. Br. 8-18). We select claim 1 as representative of the group. Any claim not argued separately will stand or fall with our analysis of the rejection regarding claim 1. FINDINGS OF FACT & ANALYSIS Appellants argue that Longoria and Y aremko fail to teach a filter comprising a mesh or a membrane of an inert material including a plurality of pores as recited in claim 1 (App. Br. 8). Appellants contend that Longoria's filter actively binds and adsorbs reacted components on or within a specially formulated filter paper having unique biochemical and ionic characteristics whereas the claim only requires passive retention of the cellular components (App. Br. 8-9). Appellants argue that Longoria's filter may be made of fiberglass or cellulose, but the fiberglass or cellulose is treated with binders and fillers to ensure control of pore size, electrostatic charge and hydrostatic characteristics (App. Br. 9). Appellants contend that Longoria's filter once treated with the binders and fillers ceases to be inert and become activated with respect to certain reactants (App. Br. 9-10). Appellants contend that the Declaration of Dr. John Roback (hereinafter the "Roback Declaration") establishes that to the ordinarily skilled artisan "inert material" in the context of the claim means "a filter that is inert with respect to the reactants [flowing through it]" (App. Br. 10-11). Appellants argue 4 Appeal2015-000424 Application 11/679,581 that Longoria's filter material electrostatically attracts the reactants and is not inert to the reactants (App. Br. 11). Appellants argue that Longoria's teaching to add binders and fillers to affect pore size and the electrostatic properties of the filter teaches away from having an inert filter that does not react with the material being filtered (App. Br. 12). Appellants argue that Longoria's disclosure in column 3, lines 49-54 that the filter may physically entrap material is not a disclosure of an inert material but rather a disclosure of physical adsorption of the filtrate to the filter (App. Br. 13-14). Appellants argue that Longoria fails to teach that the reacted components are retained above the filter (App. Br. 14). Appellants' arguments and evidence in the Roback Declaration are not persuasive because, as found by the Examiner, the proper construction of claim 1 merely requires that the filter "comprises a mesh or a membrane of an inert material including a plurality of pores." The language of claim 1 employs the open-ended claim language "comprising" in the recitation of the filter material. As such, the claims merely require an inert mesh or membrane comprised of inert material and do not exclude other additional materials in the filter. Notably, Appellants do not direct us to any portion of the Specification that defines inert material. The Specification at i-f 28 discloses that the filter may be made of cellulose acetate membrane, which Appellants consider to be an inert material. The Examiner finds that Longoria teaches that the filter is comprised of, inter alia, fiberglass or cellulose material which is an inert material (Final Act. 3; Advisory Act. 2; Ans. 4). Appellants do not contest that Longoria's cellulose mesh or membrane is made of an inert material (App. Br. 8-14). Indeed, the Specification supports the Examiner's finding that 5 Appeal2015-000424 Application 11/679,581 Longoria's cellulose is an inert material within the meaning of the properly construed claim. Accordingly, the claims do not exclude Longoria's filter composed of inert material and binder or filler. In light of the proper claim construction, Longoria does not teach away from using an inert material in the filter. Rather, Longoria teaches using inert material (i.e., fiberglass or cellulose) as part of the filter. Appellants argue that there would have been no reason to use a filter of an inert material to passively retain reactants in Longoria's filter (App. Br. 14). Contrary to Appellants' argument, the claims do not exclude Longoria' s filter comprised of inert material having binders and fillers. Accordingly, no modification of Longoria is required to meet the claims. Appellants' argument that Longoria fails to teach that the reacted components are retained above the filter is unpersuasive (App. Br. 14). The Examiner finds that Longoria must have had the material placed above the filter at some point before filtering (Ans. 5). The Examiner finds that Longoria's system is capable of having the sample placed above the filter. Id. The Examiner further finds that Y aremko teaches using filter vessels in with the placement of materials above the filter such that the combined teachings of Longoria and Y aremko would have suggested placing the material to be filtered above the filter (Ans. 5). The Examiner further finds that the filter material would have had to be placed above the filter in order to use gravity to assist in the filtration process. Id. Appellants do not contest specifically these findings. Appellants do not contest or otherwise show reversible error with regard to any of the Examiner's§ 103 rejections. On this record and for the above reasons, we affirm the Examiner's § 103 rejections of record. 6 Appeal2015-000424 Application 11/679,581 DECISION The Examiner's decision is affirmed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(l). ORDER AFFIRMED 7 Copy with citationCopy as parenthetical citation